Global Tourette Syndrome Drug Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Tourette Syndrome Drug will have significant change from previous year. According to our (LP Information) latest study, the global Tourette Syndrome Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tourette Syndrome Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Tourette Syndrome Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tourette Syndrome Drug market, reaching US$ million by the year 2028. As for the Europe Tourette Syndrome Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tourette Syndrome Drug players cover Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, and Psyadon Pharmaceuticals Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tourette Syndrome Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Tourette Syndrome Drug will have significant change from previous year. According to our (LP Information) latest study, the global Tourette Syndrome Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tourette Syndrome Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Tourette Syndrome Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tourette Syndrome Drug market, reaching US$ million by the year 2028. As for the Europe Tourette Syndrome Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tourette Syndrome Drug players cover Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, and Psyadon Pharmaceuticals Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tourette Syndrome Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- AZD-5213
- CPP-115
- Dutetrabenazine ER
- Ecopipam Hydrochloride
- Others
- Research Center
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abide Therapeutics Inc
- Catalyst Pharmaceuticals Inc
- Neurocrine Biosciences Inc
- Psyadon Pharmaceuticals Inc
- Reviva Pharmaceuticals Inc
- Synchroneuron Inc
- Teva Pharmaceutical Industries Ltd
- Therapix Biosciences Ltd
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tourette Syndrome Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Tourette Syndrome Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Tourette Syndrome Drug by Country/Region, 2017, 2022 & 2028
2.2 Tourette Syndrome Drug Segment by Type
2.2.1 AZD-5213
2.2.2 CPP-115
2.2.3 Dutetrabenazine ER
2.2.4 Ecopipam Hydrochloride
2.2.5 Others
2.3 Tourette Syndrome Drug Sales by Type
2.3.1 Global Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Tourette Syndrome Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Tourette Syndrome Drug Sale Price by Type (2017-2022)
2.4 Tourette Syndrome Drug Segment by Application
2.4.1 Research Center
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Others
2.5 Tourette Syndrome Drug Sales by Application
2.5.1 Global Tourette Syndrome Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Tourette Syndrome Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Tourette Syndrome Drug Sale Price by Application (2017-2022)
3 GLOBAL TOURETTE SYNDROME DRUG BY COMPANY
3.1 Global Tourette Syndrome Drug Breakdown Data by Company
3.1.1 Global Tourette Syndrome Drug Annual Sales by Company (2020-2022)
3.1.2 Global Tourette Syndrome Drug Sales Market Share by Company (2020-2022)
3.2 Global Tourette Syndrome Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Tourette Syndrome Drug Revenue by Company (2020-2022)
3.2.2 Global Tourette Syndrome Drug Revenue Market Share by Company (2020-2022)
3.3 Global Tourette Syndrome Drug Sale Price by Company
3.4 Key Manufacturers Tourette Syndrome Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tourette Syndrome Drug Product Location Distribution
3.4.2 Players Tourette Syndrome Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TOURETTE SYNDROME DRUG BY GEOGRAPHIC REGION
4.1 World Historic Tourette Syndrome Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Tourette Syndrome Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Tourette Syndrome Drug Annual Revenue by Geographic Region
4.2 World Historic Tourette Syndrome Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Tourette Syndrome Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Tourette Syndrome Drug Annual Revenue by Country/Region
4.3 Americas Tourette Syndrome Drug Sales Growth
4.4 APAC Tourette Syndrome Drug Sales Growth
4.5 Europe Tourette Syndrome Drug Sales Growth
4.6 Middle East & Africa Tourette Syndrome Drug Sales Growth
5 AMERICAS
5.1 Americas Tourette Syndrome Drug Sales by Country
5.1.1 Americas Tourette Syndrome Drug Sales by Country (2017-2022)
5.1.2 Americas Tourette Syndrome Drug Revenue by Country (2017-2022)
5.2 Americas Tourette Syndrome Drug Sales by Type
5.3 Americas Tourette Syndrome Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tourette Syndrome Drug Sales by Region
6.1.1 APAC Tourette Syndrome Drug Sales by Region (2017-2022)
6.1.2 APAC Tourette Syndrome Drug Revenue by Region (2017-2022)
6.2 APAC Tourette Syndrome Drug Sales by Type
6.3 APAC Tourette Syndrome Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tourette Syndrome Drug by Country
7.1.1 Europe Tourette Syndrome Drug Sales by Country (2017-2022)
7.1.2 Europe Tourette Syndrome Drug Revenue by Country (2017-2022)
7.2 Europe Tourette Syndrome Drug Sales by Type
7.3 Europe Tourette Syndrome Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tourette Syndrome Drug by Country
8.1.1 Middle East & Africa Tourette Syndrome Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Tourette Syndrome Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Tourette Syndrome Drug Sales by Type
8.3 Middle East & Africa Tourette Syndrome Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tourette Syndrome Drug
10.3 Manufacturing Process Analysis of Tourette Syndrome Drug
10.4 Industry Chain Structure of Tourette Syndrome Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tourette Syndrome Drug Distributors
11.3 Tourette Syndrome Drug Customer
12 WORLD FORECAST REVIEW FOR TOURETTE SYNDROME DRUG BY GEOGRAPHIC REGION
12.1 Global Tourette Syndrome Drug Market Size Forecast by Region
12.1.1 Global Tourette Syndrome Drug Forecast by Region (2023-2028)
12.1.2 Global Tourette Syndrome Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tourette Syndrome Drug Forecast by Type
12.7 Global Tourette Syndrome Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abide Therapeutics Inc
13.1.1 Abide Therapeutics Inc Company Information
13.1.2 Abide Therapeutics Inc Tourette Syndrome Drug Product Offered
13.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abide Therapeutics Inc Main Business Overview
13.1.5 Abide Therapeutics Inc Latest Developments
13.2 Catalyst Pharmaceuticals Inc
13.2.1 Catalyst Pharmaceuticals Inc Company Information
13.2.2 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
13.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Catalyst Pharmaceuticals Inc Main Business Overview
13.2.5 Catalyst Pharmaceuticals Inc Latest Developments
13.3 Neurocrine Biosciences Inc
13.3.1 Neurocrine Biosciences Inc Company Information
13.3.2 Neurocrine Biosciences Inc Tourette Syndrome Drug Product Offered
13.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Neurocrine Biosciences Inc Main Business Overview
13.3.5 Neurocrine Biosciences Inc Latest Developments
13.4 Psyadon Pharmaceuticals Inc
13.4.1 Psyadon Pharmaceuticals Inc Company Information
13.4.2 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
13.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Psyadon Pharmaceuticals Inc Main Business Overview
13.4.5 Psyadon Pharmaceuticals Inc Latest Developments
13.5 Reviva Pharmaceuticals Inc
13.5.1 Reviva Pharmaceuticals Inc Company Information
13.5.2 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
13.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Reviva Pharmaceuticals Inc Main Business Overview
13.5.5 Reviva Pharmaceuticals Inc Latest Developments
13.6 Synchroneuron Inc
13.6.1 Synchroneuron Inc Company Information
13.6.2 Synchroneuron Inc Tourette Syndrome Drug Product Offered
13.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Synchroneuron Inc Main Business Overview
13.6.5 Synchroneuron Inc Latest Developments
13.7 Teva Pharmaceutical Industries Ltd
13.7.1 Teva Pharmaceutical Industries Ltd Company Information
13.7.2 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Offered
13.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.8 Therapix Biosciences Ltd
13.8.1 Therapix Biosciences Ltd Company Information
13.8.2 Therapix Biosciences Ltd Tourette Syndrome Drug Product Offered
13.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Therapix Biosciences Ltd Main Business Overview
13.8.5 Therapix Biosciences Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tourette Syndrome Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Tourette Syndrome Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Tourette Syndrome Drug by Country/Region, 2017, 2022 & 2028
2.2 Tourette Syndrome Drug Segment by Type
2.2.1 AZD-5213
2.2.2 CPP-115
2.2.3 Dutetrabenazine ER
2.2.4 Ecopipam Hydrochloride
2.2.5 Others
2.3 Tourette Syndrome Drug Sales by Type
2.3.1 Global Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Tourette Syndrome Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Tourette Syndrome Drug Sale Price by Type (2017-2022)
2.4 Tourette Syndrome Drug Segment by Application
2.4.1 Research Center
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Others
2.5 Tourette Syndrome Drug Sales by Application
2.5.1 Global Tourette Syndrome Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Tourette Syndrome Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Tourette Syndrome Drug Sale Price by Application (2017-2022)
3 GLOBAL TOURETTE SYNDROME DRUG BY COMPANY
3.1 Global Tourette Syndrome Drug Breakdown Data by Company
3.1.1 Global Tourette Syndrome Drug Annual Sales by Company (2020-2022)
3.1.2 Global Tourette Syndrome Drug Sales Market Share by Company (2020-2022)
3.2 Global Tourette Syndrome Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Tourette Syndrome Drug Revenue by Company (2020-2022)
3.2.2 Global Tourette Syndrome Drug Revenue Market Share by Company (2020-2022)
3.3 Global Tourette Syndrome Drug Sale Price by Company
3.4 Key Manufacturers Tourette Syndrome Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tourette Syndrome Drug Product Location Distribution
3.4.2 Players Tourette Syndrome Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TOURETTE SYNDROME DRUG BY GEOGRAPHIC REGION
4.1 World Historic Tourette Syndrome Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Tourette Syndrome Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Tourette Syndrome Drug Annual Revenue by Geographic Region
4.2 World Historic Tourette Syndrome Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Tourette Syndrome Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Tourette Syndrome Drug Annual Revenue by Country/Region
4.3 Americas Tourette Syndrome Drug Sales Growth
4.4 APAC Tourette Syndrome Drug Sales Growth
4.5 Europe Tourette Syndrome Drug Sales Growth
4.6 Middle East & Africa Tourette Syndrome Drug Sales Growth
5 AMERICAS
5.1 Americas Tourette Syndrome Drug Sales by Country
5.1.1 Americas Tourette Syndrome Drug Sales by Country (2017-2022)
5.1.2 Americas Tourette Syndrome Drug Revenue by Country (2017-2022)
5.2 Americas Tourette Syndrome Drug Sales by Type
5.3 Americas Tourette Syndrome Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tourette Syndrome Drug Sales by Region
6.1.1 APAC Tourette Syndrome Drug Sales by Region (2017-2022)
6.1.2 APAC Tourette Syndrome Drug Revenue by Region (2017-2022)
6.2 APAC Tourette Syndrome Drug Sales by Type
6.3 APAC Tourette Syndrome Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tourette Syndrome Drug by Country
7.1.1 Europe Tourette Syndrome Drug Sales by Country (2017-2022)
7.1.2 Europe Tourette Syndrome Drug Revenue by Country (2017-2022)
7.2 Europe Tourette Syndrome Drug Sales by Type
7.3 Europe Tourette Syndrome Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tourette Syndrome Drug by Country
8.1.1 Middle East & Africa Tourette Syndrome Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Tourette Syndrome Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Tourette Syndrome Drug Sales by Type
8.3 Middle East & Africa Tourette Syndrome Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tourette Syndrome Drug
10.3 Manufacturing Process Analysis of Tourette Syndrome Drug
10.4 Industry Chain Structure of Tourette Syndrome Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tourette Syndrome Drug Distributors
11.3 Tourette Syndrome Drug Customer
12 WORLD FORECAST REVIEW FOR TOURETTE SYNDROME DRUG BY GEOGRAPHIC REGION
12.1 Global Tourette Syndrome Drug Market Size Forecast by Region
12.1.1 Global Tourette Syndrome Drug Forecast by Region (2023-2028)
12.1.2 Global Tourette Syndrome Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tourette Syndrome Drug Forecast by Type
12.7 Global Tourette Syndrome Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abide Therapeutics Inc
13.1.1 Abide Therapeutics Inc Company Information
13.1.2 Abide Therapeutics Inc Tourette Syndrome Drug Product Offered
13.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abide Therapeutics Inc Main Business Overview
13.1.5 Abide Therapeutics Inc Latest Developments
13.2 Catalyst Pharmaceuticals Inc
13.2.1 Catalyst Pharmaceuticals Inc Company Information
13.2.2 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
13.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Catalyst Pharmaceuticals Inc Main Business Overview
13.2.5 Catalyst Pharmaceuticals Inc Latest Developments
13.3 Neurocrine Biosciences Inc
13.3.1 Neurocrine Biosciences Inc Company Information
13.3.2 Neurocrine Biosciences Inc Tourette Syndrome Drug Product Offered
13.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Neurocrine Biosciences Inc Main Business Overview
13.3.5 Neurocrine Biosciences Inc Latest Developments
13.4 Psyadon Pharmaceuticals Inc
13.4.1 Psyadon Pharmaceuticals Inc Company Information
13.4.2 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
13.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Psyadon Pharmaceuticals Inc Main Business Overview
13.4.5 Psyadon Pharmaceuticals Inc Latest Developments
13.5 Reviva Pharmaceuticals Inc
13.5.1 Reviva Pharmaceuticals Inc Company Information
13.5.2 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
13.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Reviva Pharmaceuticals Inc Main Business Overview
13.5.5 Reviva Pharmaceuticals Inc Latest Developments
13.6 Synchroneuron Inc
13.6.1 Synchroneuron Inc Company Information
13.6.2 Synchroneuron Inc Tourette Syndrome Drug Product Offered
13.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Synchroneuron Inc Main Business Overview
13.6.5 Synchroneuron Inc Latest Developments
13.7 Teva Pharmaceutical Industries Ltd
13.7.1 Teva Pharmaceutical Industries Ltd Company Information
13.7.2 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Offered
13.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.8 Therapix Biosciences Ltd
13.8.1 Therapix Biosciences Ltd Company Information
13.8.2 Therapix Biosciences Ltd Tourette Syndrome Drug Product Offered
13.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Therapix Biosciences Ltd Main Business Overview
13.8.5 Therapix Biosciences Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tourette Syndrome Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Tourette Syndrome Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of AZD-5213
Table 4. Major Players of CPP-115
Table 5. Major Players of Dutetrabenazine ER
Table 6. Major Players of Ecopipam Hydrochloride
Table 7. Major Players of Others
Table 8. Global Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 10. Global Tourette Syndrome Drug Revenue by Type (2017-2022) & ($ million)
Table 11. Global Tourette Syndrome Drug Revenue Market Share by Type (2017-2022)
Table 12. Global Tourette Syndrome Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 15. Global Tourette Syndrome Drug Revenue by Application (2017-2022)
Table 16. Global Tourette Syndrome Drug Revenue Market Share by Application (2017-2022)
Table 17. Global Tourette Syndrome Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Tourette Syndrome Drug Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Tourette Syndrome Drug Sales Market Share by Company (2020-2022)
Table 20. Global Tourette Syndrome Drug Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Tourette Syndrome Drug Revenue Market Share by Company (2020-2022)
Table 22. Global Tourette Syndrome Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Tourette Syndrome Drug Producing Area Distribution and Sales Area
Table 24. Players Tourette Syndrome Drug Products Offered
Table 25. Tourette Syndrome Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Tourette Syndrome Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Tourette Syndrome Drug Sales Market Share Geographic Region (2017-2022)
Table 30. Global Tourette Syndrome Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Tourette Syndrome Drug Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Tourette Syndrome Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Tourette Syndrome Drug Sales Market Share by Country/Region (2017-2022)
Table 34. Global Tourette Syndrome Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Tourette Syndrome Drug Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Tourette Syndrome Drug Sales Market Share by Country (2017-2022)
Table 38. Americas Tourette Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Tourette Syndrome Drug Revenue Market Share by Country (2017-2022)
Table 40. Americas Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 42. Americas Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 44. APAC Tourette Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Tourette Syndrome Drug Sales Market Share by Region (2017-2022)
Table 46. APAC Tourette Syndrome Drug Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Tourette Syndrome Drug Revenue Market Share by Region (2017-2022)
Table 48. APAC Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 50. APAC Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 52. Europe Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Tourette Syndrome Drug Sales Market Share by Country (2017-2022)
Table 54. Europe Tourette Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Tourette Syndrome Drug Revenue Market Share by Country (2017-2022)
Table 56. Europe Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 58. Europe Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Tourette Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Tourette Syndrome Drug Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Tourette Syndrome Drug
Table 69. Key Market Challenges & Risks of Tourette Syndrome Drug
Table 70. Key Industry Trends of Tourette Syndrome Drug
Table 71. Tourette Syndrome Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Tourette Syndrome Drug Distributors List
Table 74. Tourette Syndrome Drug Customer List
Table 75. Global Tourette Syndrome Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Tourette Syndrome Drug Sales Market Forecast by Region
Table 77. Global Tourette Syndrome Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Tourette Syndrome Drug Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Tourette Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Tourette Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Tourette Syndrome Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Tourette Syndrome Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Tourette Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Tourette Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Tourette Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Tourette Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Tourette Syndrome Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Tourette Syndrome Drug Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Tourette Syndrome Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Tourette Syndrome Drug Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Tourette Syndrome Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Tourette Syndrome Drug Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Tourette Syndrome Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Tourette Syndrome Drug Revenue Market Share Forecast by Application (2023-2028)
Table 95. Abide Therapeutics Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Abide Therapeutics Inc Tourette Syndrome Drug Product Offered
Table 97. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Abide Therapeutics Inc Main Business
Table 99. Abide Therapeutics Inc Latest Developments
Table 100. Catalyst Pharmaceuticals Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
Table 102. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Catalyst Pharmaceuticals Inc Main Business
Table 104. Catalyst Pharmaceuticals Inc Latest Developments
Table 105. Neurocrine Biosciences Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Neurocrine Biosciences Inc Tourette Syndrome Drug Product Offered
Table 107. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Neurocrine Biosciences Inc Main Business
Table 109. Neurocrine Biosciences Inc Latest Developments
Table 110. Psyadon Pharmaceuticals Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
Table 112. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Psyadon Pharmaceuticals Inc Main Business
Table 114. Psyadon Pharmaceuticals Inc Latest Developments
Table 115. Reviva Pharmaceuticals Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
Table 117. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Reviva Pharmaceuticals Inc Main Business
Table 119. Reviva Pharmaceuticals Inc Latest Developments
Table 120. Synchroneuron Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Synchroneuron Inc Tourette Syndrome Drug Product Offered
Table 122. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Synchroneuron Inc Main Business
Table 124. Synchroneuron Inc Latest Developments
Table 125. Teva Pharmaceutical Industries Ltd Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Offered
Table 127. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Teva Pharmaceutical Industries Ltd Main Business
Table 129. Teva Pharmaceutical Industries Ltd Latest Developments
Table 130. Therapix Biosciences Ltd Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Therapix Biosciences Ltd Tourette Syndrome Drug Product Offered
Table 132. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Therapix Biosciences Ltd Main Business
Table 134. Therapix Biosciences Ltd Latest Developments
Table 1. Tourette Syndrome Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Tourette Syndrome Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of AZD-5213
Table 4. Major Players of CPP-115
Table 5. Major Players of Dutetrabenazine ER
Table 6. Major Players of Ecopipam Hydrochloride
Table 7. Major Players of Others
Table 8. Global Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 10. Global Tourette Syndrome Drug Revenue by Type (2017-2022) & ($ million)
Table 11. Global Tourette Syndrome Drug Revenue Market Share by Type (2017-2022)
Table 12. Global Tourette Syndrome Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 15. Global Tourette Syndrome Drug Revenue by Application (2017-2022)
Table 16. Global Tourette Syndrome Drug Revenue Market Share by Application (2017-2022)
Table 17. Global Tourette Syndrome Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Tourette Syndrome Drug Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Tourette Syndrome Drug Sales Market Share by Company (2020-2022)
Table 20. Global Tourette Syndrome Drug Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Tourette Syndrome Drug Revenue Market Share by Company (2020-2022)
Table 22. Global Tourette Syndrome Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Tourette Syndrome Drug Producing Area Distribution and Sales Area
Table 24. Players Tourette Syndrome Drug Products Offered
Table 25. Tourette Syndrome Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Tourette Syndrome Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Tourette Syndrome Drug Sales Market Share Geographic Region (2017-2022)
Table 30. Global Tourette Syndrome Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Tourette Syndrome Drug Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Tourette Syndrome Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Tourette Syndrome Drug Sales Market Share by Country/Region (2017-2022)
Table 34. Global Tourette Syndrome Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Tourette Syndrome Drug Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Tourette Syndrome Drug Sales Market Share by Country (2017-2022)
Table 38. Americas Tourette Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Tourette Syndrome Drug Revenue Market Share by Country (2017-2022)
Table 40. Americas Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 42. Americas Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 44. APAC Tourette Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Tourette Syndrome Drug Sales Market Share by Region (2017-2022)
Table 46. APAC Tourette Syndrome Drug Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Tourette Syndrome Drug Revenue Market Share by Region (2017-2022)
Table 48. APAC Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 50. APAC Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 52. Europe Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Tourette Syndrome Drug Sales Market Share by Country (2017-2022)
Table 54. Europe Tourette Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Tourette Syndrome Drug Revenue Market Share by Country (2017-2022)
Table 56. Europe Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 58. Europe Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Tourette Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Tourette Syndrome Drug Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Tourette Syndrome Drug Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Tourette Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Tourette Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Tourette Syndrome Drug
Table 69. Key Market Challenges & Risks of Tourette Syndrome Drug
Table 70. Key Industry Trends of Tourette Syndrome Drug
Table 71. Tourette Syndrome Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Tourette Syndrome Drug Distributors List
Table 74. Tourette Syndrome Drug Customer List
Table 75. Global Tourette Syndrome Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Tourette Syndrome Drug Sales Market Forecast by Region
Table 77. Global Tourette Syndrome Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Tourette Syndrome Drug Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Tourette Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Tourette Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Tourette Syndrome Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Tourette Syndrome Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Tourette Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Tourette Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Tourette Syndrome Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Tourette Syndrome Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Tourette Syndrome Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Tourette Syndrome Drug Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Tourette Syndrome Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Tourette Syndrome Drug Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Tourette Syndrome Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Tourette Syndrome Drug Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Tourette Syndrome Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Tourette Syndrome Drug Revenue Market Share Forecast by Application (2023-2028)
Table 95. Abide Therapeutics Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Abide Therapeutics Inc Tourette Syndrome Drug Product Offered
Table 97. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Abide Therapeutics Inc Main Business
Table 99. Abide Therapeutics Inc Latest Developments
Table 100. Catalyst Pharmaceuticals Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
Table 102. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Catalyst Pharmaceuticals Inc Main Business
Table 104. Catalyst Pharmaceuticals Inc Latest Developments
Table 105. Neurocrine Biosciences Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Neurocrine Biosciences Inc Tourette Syndrome Drug Product Offered
Table 107. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Neurocrine Biosciences Inc Main Business
Table 109. Neurocrine Biosciences Inc Latest Developments
Table 110. Psyadon Pharmaceuticals Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
Table 112. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Psyadon Pharmaceuticals Inc Main Business
Table 114. Psyadon Pharmaceuticals Inc Latest Developments
Table 115. Reviva Pharmaceuticals Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Offered
Table 117. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Reviva Pharmaceuticals Inc Main Business
Table 119. Reviva Pharmaceuticals Inc Latest Developments
Table 120. Synchroneuron Inc Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Synchroneuron Inc Tourette Syndrome Drug Product Offered
Table 122. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Synchroneuron Inc Main Business
Table 124. Synchroneuron Inc Latest Developments
Table 125. Teva Pharmaceutical Industries Ltd Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Offered
Table 127. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Teva Pharmaceutical Industries Ltd Main Business
Table 129. Teva Pharmaceutical Industries Ltd Latest Developments
Table 130. Therapix Biosciences Ltd Basic Information, Tourette Syndrome Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Therapix Biosciences Ltd Tourette Syndrome Drug Product Offered
Table 132. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Therapix Biosciences Ltd Main Business
Table 134. Therapix Biosciences Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tourette Syndrome Drug
Figure 2. Tourette Syndrome Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tourette Syndrome Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Tourette Syndrome Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Tourette Syndrome Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of AZD-5213
Figure 10. Product Picture of CPP-115
Figure 11. Product Picture of Dutetrabenazine ER
Figure 12. Product Picture of Ecopipam Hydrochloride
Figure 13. Product Picture of Others
Figure 14. Global Tourette Syndrome Drug Sales Market Share by Type in 2021
Figure 15. Global Tourette Syndrome Drug Revenue Market Share by Type (2017-2022)
Figure 16. Tourette Syndrome Drug Consumed in Research Center
Figure 17. Global Tourette Syndrome Drug Market: Research Center (2017-2022) & (K Pcs)
Figure 18. Tourette Syndrome Drug Consumed in Hospital
Figure 19. Global Tourette Syndrome Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Tourette Syndrome Drug Consumed in Clinic
Figure 21. Global Tourette Syndrome Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 22. Tourette Syndrome Drug Consumed in Others
Figure 23. Global Tourette Syndrome Drug Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Tourette Syndrome Drug Revenue Market Share by Application in 2021
Figure 26. Tourette Syndrome Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Tourette Syndrome Drug Revenue Market Share by Company in 2021
Figure 28. Global Tourette Syndrome Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Tourette Syndrome Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Tourette Syndrome Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Tourette Syndrome Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Tourette Syndrome Drug Sales 2017-2022 (K Pcs)
Figure 33. Americas Tourette Syndrome Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Tourette Syndrome Drug Sales 2017-2022 (K Pcs)
Figure 35. APAC Tourette Syndrome Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Tourette Syndrome Drug Sales 2017-2022 (K Pcs)
Figure 37. Europe Tourette Syndrome Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Tourette Syndrome Drug Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Tourette Syndrome Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Tourette Syndrome Drug Sales Market Share by Country in 2021
Figure 41. Americas Tourette Syndrome Drug Revenue Market Share by Country in 2021
Figure 42. United States Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Tourette Syndrome Drug Sales Market Share by Region in 2021
Figure 47. APAC Tourette Syndrome Drug Revenue Market Share by Regions in 2021
Figure 48. China Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Tourette Syndrome Drug Sales Market Share by Country in 2021
Figure 55. Europe Tourette Syndrome Drug Revenue Market Share by Country in 2021
Figure 56. Germany Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Tourette Syndrome Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Tourette Syndrome Drug in 2021
Figure 69. Manufacturing Process Analysis of Tourette Syndrome Drug
Figure 70. Industry Chain Structure of Tourette Syndrome Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 1. Picture of Tourette Syndrome Drug
Figure 2. Tourette Syndrome Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tourette Syndrome Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Tourette Syndrome Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Tourette Syndrome Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of AZD-5213
Figure 10. Product Picture of CPP-115
Figure 11. Product Picture of Dutetrabenazine ER
Figure 12. Product Picture of Ecopipam Hydrochloride
Figure 13. Product Picture of Others
Figure 14. Global Tourette Syndrome Drug Sales Market Share by Type in 2021
Figure 15. Global Tourette Syndrome Drug Revenue Market Share by Type (2017-2022)
Figure 16. Tourette Syndrome Drug Consumed in Research Center
Figure 17. Global Tourette Syndrome Drug Market: Research Center (2017-2022) & (K Pcs)
Figure 18. Tourette Syndrome Drug Consumed in Hospital
Figure 19. Global Tourette Syndrome Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Tourette Syndrome Drug Consumed in Clinic
Figure 21. Global Tourette Syndrome Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 22. Tourette Syndrome Drug Consumed in Others
Figure 23. Global Tourette Syndrome Drug Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Tourette Syndrome Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Tourette Syndrome Drug Revenue Market Share by Application in 2021
Figure 26. Tourette Syndrome Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Tourette Syndrome Drug Revenue Market Share by Company in 2021
Figure 28. Global Tourette Syndrome Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Tourette Syndrome Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Tourette Syndrome Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Tourette Syndrome Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Tourette Syndrome Drug Sales 2017-2022 (K Pcs)
Figure 33. Americas Tourette Syndrome Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Tourette Syndrome Drug Sales 2017-2022 (K Pcs)
Figure 35. APAC Tourette Syndrome Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Tourette Syndrome Drug Sales 2017-2022 (K Pcs)
Figure 37. Europe Tourette Syndrome Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Tourette Syndrome Drug Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Tourette Syndrome Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Tourette Syndrome Drug Sales Market Share by Country in 2021
Figure 41. Americas Tourette Syndrome Drug Revenue Market Share by Country in 2021
Figure 42. United States Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Tourette Syndrome Drug Sales Market Share by Region in 2021
Figure 47. APAC Tourette Syndrome Drug Revenue Market Share by Regions in 2021
Figure 48. China Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Tourette Syndrome Drug Sales Market Share by Country in 2021
Figure 55. Europe Tourette Syndrome Drug Revenue Market Share by Country in 2021
Figure 56. Germany Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Tourette Syndrome Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Tourette Syndrome Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Tourette Syndrome Drug in 2021
Figure 69. Manufacturing Process Analysis of Tourette Syndrome Drug
Figure 70. Industry Chain Structure of Tourette Syndrome Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
